AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2018
Jun 12, 2018
31565_dirs_2018-06-12_c1f90231-fad1-43c8-8afa-82f01112e653.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2018-06-08
Reporting Person: Goldstein Dan (VP, Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-08 | Common Stock | S | 578 | $92.90 | Disposed | 3022 | Direct |
Footnotes
F1: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2018.
F2: This number includes unvested restricted stock units previously reported.
More from HAEMONETICS CORP
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 4
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12